Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

1.5K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.5K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Epigenetic Regulation01:37

Epigenetic Regulation

3.5K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Epigenetic Regulation01:46

Epigenetic Regulation

28.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Epigenetic Regulation01:46

Epigenetic Regulation

24.1K
24.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hybridndiff-UQ: Uncertainty quantification for hybrid neural differentiable modeling.

Theoretical and applied mechanics letters·2026
Same author

CoNFiLD-inlet: Synthetic turbulence inflow using generative latent diffusion models with neural fields.

Physical review fluids·2026
Same author

DIRECT MEDICAL IMAGE TO SIMULATION USING AUTO-SEGMENTATION AND POINT CLOUD-BASED CFD.

Advances in computational science and engineering·2026
Same author

Caffeine intake is linked to depressive symptoms in patients with heart failure: An analysis based on NHANES, 2005 to 2018.

Medicine·2025
Same author

AortaDiff: Volume-Guided Conditional Diffusion Models for Multi-Branch Aortic Surface Generation.

IEEE transactions on visualization and computer graphics·2025
Same author

HIERARCHICAL LOG BAYESIAN NEURAL NETWORK FOR ENHANCED AORTA SEGMENTATION.

Proceedings. IEEE International Symposium on Biomedical Imaging·2025
Same journal

Age-related morphological and histological changes in the dromedary camel thymus.

Histology and histopathology·2026
Same journal

Isofraxidin ameliorates CCl<sub>4</sub>-induced liver fibrosis in mice by inhibiting the NF-κB pathway.

Histology and histopathology·2026
Same journal

FOXO3/HMOX1 axis promotes melanoma progression by regulating ferroptosis and immune escape.

Histology and histopathology·2026
Same journal

Immunohistochemical evaluation of CD44 expression and its correlation with clinicopathological factors and molecular markers (EGFR, STAT3, and lipid metabolism-related proteins) in oral squamous cell carcinoma.

Histology and histopathology·2026
Same journal

Betulinic acid mitigates septic cardiomyopathy in mice through modulating the TLR4/MyD88/NF-κB signaling axis and NLRP3 inflammasome pathway.

Histology and histopathology·2026
Same journal

Extension loss following ACL reconstruction: A narrative review of mechanisms and phase-specific management.

Histology and histopathology·2026
See all related articles

Related Experiment Video

Updated: Apr 30, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.7K

PiRNAs link epigenetic modifications to reprogramming.

Yin Wang1, Teng Sun1, Kun Wang1

  • 1Division of Cardiovascular research, State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Histology and Histopathology
|April 25, 2014
PubMed
Summary
This summary is machine-generated.

Piwi-interacting RNAs (piRNAs) act as barriers to cell reprogramming by maintaining epigenetic suppression. Overcoming these piRNA-derived barriers is crucial for efficient reprogramming of somatic cells into pluripotent stem cells.

More Related Videos

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.1K
CRISPR-Mediated Reorganization of Chromatin Loop Structure
09:20

CRISPR-Mediated Reorganization of Chromatin Loop Structure

Published on: September 14, 2018

14.2K

Related Experiment Videos

Last Updated: Apr 30, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.7K
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.1K
CRISPR-Mediated Reorganization of Chromatin Loop Structure
09:20

CRISPR-Mediated Reorganization of Chromatin Loop Structure

Published on: September 14, 2018

14.2K

Area of Science:

  • Epigenetics and Gene Regulation
  • Stem Cell Biology
  • Non-coding RNA Research

Background:

  • Cell reprogramming involves altering epigenetic landscapes (histone modification, DNA methylation, non-coding RNAs) to change cell fate.
  • A major challenge is overcoming epigenetic suppression in differentiated cells, which hinders the establishment of pluripotency.
  • Piwi-interacting RNAs (piRNAs) are small non-coding RNAs involved in transposon silencing and epigenetic regulation.

Purpose of the Study:

  • To review recent advances on the role of piRNAs as barriers to cell reprogramming.
  • To highlight the necessity of overcoming piRNA-mediated epigenetic silencing for successful reprogramming.
  • To explore how understanding piRNA mechanisms can advance somatic cell reprogramming.

Main Methods:

  • Literature review of recent studies on piRNAs and cell reprogramming.
  • Analysis of proposed and demonstrated roles of piRNAs in epigenetic suppression during reprogramming.
  • Discussion of the mechanistic insights into piRNA-mediated epigenetic regulation.

Main Results:

  • PiRNAs have been implicated as significant barriers to cell reprogramming.
  • These piRNAs exert epigenetic silencing, preventing the attainment of desired cell fates or pluripotency.
  • Overcoming piRNA-derived barriers is presented as a key requirement for efficient reprogramming.

Conclusions:

  • PiRNAs function as epigenetic suppressors that impede cell reprogramming.
  • Targeting or understanding piRNA mechanisms is essential for advancing reprogramming technologies.
  • Further research into piRNA-mediated epigenetic regulation may unlock efficient somatic cell reprogramming.